Advertisement
PerkinElmer
PerkinElmer

Multimedia

» antibiotic resistance and cancer

Video, Slideshows, Infographics

Most Recent

image: <em>The Scientist</em> on the Pulse, April 23

The Scientist on the Pulse, April 23

By | April 23, 2015

Hot topics in cancer research from the annual meeting of the American Association for Cancer Research

0 Comments

image: Cancer Immunotherapist

Cancer Immunotherapist

By | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

0 Comments

image: Tracking Miracles

Tracking Miracles

By | April 1, 2015

A panel of oncologists discusses cases of exceptional responders, or cancer patients whose tumors disappear after a brief period of chemotherapy.

0 Comments

image: Poor Little Devils

Poor Little Devils

By | November 1, 2014

See the devastating infectious cancer that may drive the Tasmanian Devil to extinction.

0 Comments

image: Targeting Tumors with Viruses

Targeting Tumors with Viruses

By | June 1, 2014

Stephanie Swift discusses the strategy of fighting cancer with viruses.

0 Comments

image: Superbugs Ascending

Superbugs Ascending

By | April 1, 2014

University of Texas at San Antonio microbiologist Karl Klose discusses the problem of antibiotic resistance in a 2013 TEDx talk.

0 Comments

image: Cancer Whisperer

Cancer Whisperer

By | July 1, 2013

Profile subject Cédric Blanpain describes his work rooting out the role of stem cells in tumors.

0 Comments

image: Blue Biotech

Blue Biotech

By | March 1, 2013

Systems biologist Lone Gram describes her approach to combing the oceans for novel compounds that may be useful in the fight against pathogens.

0 Comments

image: Telomere Basics

Telomere Basics

By | May 1, 2012

Telomeres are repetitive, noncoding sequences that cap the ends of linear chromosomes. They consist of hexameric nucleotide sequences (TTAGGG in humans) repeated hundreds to thousands of times. 

4 Comments

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

0 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
BioLegend
BioLegend
Advertisement
The Scientist